Pathogenicity and vaccine efficacy of two virulent infectious laryngotracheitis virus strains in Egypt
Open Access
- 26 September 2022
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Veterinary Research
- Vol. 18 (1), 1-11
- https://doi.org/10.1186/s12917-022-03458-3
Abstract
Infectious laryngotracheitis (ILT) is an economically crucial respiratory disease of poultry that affects the industry worldwide. Vaccination is the principal tool in the control of the disease outbreak. In an earlier study, we comprehensively characterized the circulating strains in Egypt and identified both CEO-like and recombinant strains are dominant. Herein, we investigated the pathogenicity of two virulent strains representing the CEO-like (Sharkia_2018) and recombinant strain (Qalubia_2018). Additionally, we evaluated the efficacy of different commercial vaccines (HVT-LT, CEO, and TCO) against the two isolates in terms of the histopathological lesion scores and the viral (gC) gene load. A total of 270 White Leghorn-specific pathogen-free male chicks were divided into nine groups of 30 birds, each housed in separate isolators. Birds were distributed as follows; one group was non-vaccinated, non-challenged, and served as a negative control. Two groups were non-vaccinated and infected with the two isolates of interest and served as a positive control to test the pathogenicity. Six groups were vaccinated and challenged; two groups were vaccinated with vector vaccine at one day old. The other four groups were vaccinated with either the CEO- or TCO- vaccine (two groups each) at four weeks of age. Three weeks after vaccination, birds were infected with the virulent ILTV isolates. The larynx, trachea, and harderian gland samples were taken at 1, 3, and 7 days post-infection for histopathological lesion score and molecular detection. Notably, The recombinant strain was more virulent and pathogenic than CEO-like ILTV strains. Moreover, the TCO vaccine was less immunogenic than the vector and CEO vaccines.Keywords
Funding Information
- Cairo University
This publication has 32 references indexed in Scilit:
- Challenges and recent advancements in infectious laryngotracheitis virus vaccinesAvian Pathology, 2013
- Chicken embryo origin-like strains are responsible for Infectious laryngotracheitis virus outbreaks in Egyptian cross-bred broiler chickensVirus Genes, 2013
- Protection Against Infectious Laryngotracheitis by In Ovo Vaccination with Commercially Available Viral Vector Recombinant VaccinesAvian Diseases, 2010
- The order HerpesviralesArchiv für die gesamte Virusforschung, 2008
- Evaluation of the protection elicited by direct and indirect exposure to live attenuated infectious laryngotracheitis virus vaccines against a recent challenge strain from the United StatesAvian Pathology, 2008
- Kinetics of Marek's disease virus (MDV) infection in broiler chickens 1: effect of varying vaccination to challenge interval on vaccinal protection and load of MDV and herpesvirus of turkey in the spleen and feather dander over timeAvian Pathology, 2008
- Characterization of Infectious Laryngotracheitis Virus (ILTV) Isolates from Commercial Poultry by Polymerase Chain Reaction and Restriction Fragment Length Polymorphism (PCR-RFLP)Avian Diseases, 2008
- Epizootiology of Infectious Laryngotracheitis and Presentation of an Industry Control ProgramAvian Diseases, 2008
- Development and Use of Fowlpox Vectored Vaccines for Avian InfluenzaAnnals of the New York Academy of Sciences, 2006
- Evaluation of the Efficacy of a Live Fowlpox-Vectored Infectious Laryngotracheitis/Avian Encephalomyelitis Vaccine Against ILT Viral ChallengeAvian Diseases, 2006